Key result
New agents and digital health technologies enhance individualized antihypertensive care through precision medicine.
Why the study?
Hypertension remains a leading cause of morbidity and mortality, while antihypertensive pharmacotherapy, precision medicine, and digital health technologies continue to evolve.
Design
Comprehensive review
Hypertension management is evolving through improved mechanisms, combination approaches, novel drugs like SGLT2 inhibitors, and digital innovations.
Hypertension is a leading global cause of morbidity and mortality.[4–6], contributing to cardiovascular, renal, and cerebrovascular disease. Antihypertensive pharmacotherapy continues to evolve, with new agents, combination strategies, and device-basedinterventions.[18–23] Precision medicine, pharmacogenomics.[26–28] and digital health technologies.[24–25] are reshaping individualized care. Overview of Major Antihypertensive Drug Classes (Section supported by Goodman & Gilman.[1], Katzung[2], Rang & Dale.[3]
No takes yet. Share an insight, caveat, or question.
Snehal Genbhau Tengle*1, Dr. Amita B. Dongar2, Ms. Ashlesha Gaikwad3 (2026) studied this question. Antihypertensive pharmacotherapy is evolving with new agents and strategies that enhance individualized care through precision medicine and digital health technologies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: